IL-4 and Brentuximab Vedotin in Mycosis Fungoides: A Perspective on Potential Therapeutic Interactions and Future Research Directions
Background: Mycosis fungoides (MF), the most prevalent cutaneous T cell lymphoma, features clonal CD4⁺ T cell proliferation within a Th2-dominant microenvironment. Interleukin-4 (IL-4) promotes disease progression while Brentuximab Vedotin (BV), an anti-CD30 antibody–drug conjugate, shows efficacy b...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-07-01
|
| Col·lecció: | Current Issues in Molecular Biology |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1467-3045/47/8/586 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|